Table 4.
Summary Table of Included Studies
| Paper characteristics | n (%) | Paper characteristics | n (%) |
|---|---|---|---|
| Study design | Country | ||
| Cross-sectional | 19 (55.9%) | United States | 13 (39.3%) |
| Longitudinal | 10 (28.6) | Canada | 5 (14.7%) |
| Prospective/retrospective cohort | 3 (8.8%) | United Kingdom | 5 (14.7%) |
| Systematic review | 1 (2.9%) | Australia | 2 (5.9%) |
| Case control | 1 | Serbia | 1 (2.9%) |
| Spain | 1 | ||
| Journal | Israel | 1 | |
| Psycho-oncology | 5 (14.7%) | Norway | 1 |
| Journal of Clinical Oncology | 4 (11.8%) | Pakistan | 1 |
| Supportive Care in Cancer | 3 (8.8%) | Germany | 3 |
| British Journal of Cancer | 3 | Finland | 1 |
| Journal of Psychosocial Oncology | 2 (5.9%) | ||
| European Journal of Cancer | 2 | Tumor groups sampled | |
| British Medical Journal | 1 (2.9%) | Breast | 15 (41.1%) |
| Journal of Geriatric Oncology | 1 | Mixed diagnoses | 10 (28.6%) |
| Journal of Consulting and Clinical Psychology | 1 | Ovarian | 3 (8.8%) |
| Gynecologic Oncology | 1 | Colorectal | 3 |
| Health Psychology | 1 | Testicular | 1 (2.9%) |
| British Journal of Health Psychology | 1 | Endometrial | 1 |
| The Breast | 1 | Melanoma | 1 |
| BMC Cancer | 1 | Hematological | 1 |
| Journal of Hospice & Palliative Nursing | 1 | ||
| Journal of Affective Disorders | 1 | Year published | |
| PLOS One | 1 | 1999 | 1 (2.9%) |
| Journal of Psychosomatic Research | 1 | 2000–2004 | 5 (17.6%) |
| Clinical Oncology | 1 | 2005–2009 | 9 (26.5%) |
| Cancer | 1 | 2010–2014 | 19 (55.9%) |
| Breast Cancer Research and Treatment | 1 | ||
| Radiotherapy and Oncology | 1 | Time since diagnosis* | |
| On-treatment (patient) | 25 (73.5%) | ||
| Treatment of age in analysis | Post-treatment (survivor) | 13 (37.1%) | |
| Categorical | 15 (44.1%) | ||
| Continuous | 21 (61.8%) | ||
*
Does not sum to 34, as some longitudinal studies followed people from the time of treatment up to 5 years.